Certain X-Ray Breast Imaging Devices and Components Thereof; Notice of Commission Decision To Terminate the Investigation Based on Settlement; Termination of the Investigation, 4854-4855 [2019-02671]

Download as PDF 4854 Federal Register / Vol. 84, No. 33 / Tuesday, February 19, 2019 / Notices the President and Congress no later than 105 days after the President entered into the agreement plus an additional 35 days. All other dates pertaining to this investigation remain the same as in the notice published in the Federal Register on October 16, 2018. By order of the Commission. Issued: February 12, 2019. Lisa Barton, Secretary to the Commission. [FR Doc. 2019–02603 Filed 2–15–19; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Investigation No. 332–569] U.S. SME Exports: Trade-Related Barriers Affecting Exports of U.S. Small- and Medium-Sized Enterprises to the United Kingdom United States International Trade Commission. ACTION: Notice, change in dates. AGENCY: Due to the lapse of appropriation between December 22, 2018 and January 25, 2019, the Commission has changed certain dates announced in its notice of investigation and hearing for these investigations: (i) It has extended the deadline for filing requests to appear at the public hearing from February 8, 2019 to March 28, 2019; (ii) it has extended the deadline for filing prehearing briefs and statements from February 13, 2019 to April 1, 2019; (iii) it has rescheduled the public hearing from February 26, 2019 to April 11, 2019; (iv) it has extended the deadline for filing post-hearing briefs from March 8, 2019 to April 18, 2019; (v) it has extended the deadline for filing all other written submissions from March 15, 2019 to April 30, 2019; and (vi) it will transmit its report to the USTR by September 4, 2019 instead of by July 31, 2019. DATES: February 11, 2019. FOR FURTHER INFORMATION CONTACT: Project Leader Mahnaz Khan (202–205– 2046 or Mahnaz.khan@usitc.gov) or Deputy Project Leader Sarah Scott (202– 708–1397 or sarah.scott@usitc.gov) for information specific to these investigations. For information on the legal aspects of these investigations, contact William Gearhart of the Commission’s Office of the General Counsel (202–205–3091 or william.gearhart@usitc.gov). The media should contact Margaret O’Laughlin, Office of External Relations (202–205– 1819 or margaret.olaughlin@usitc.gov). Hearing-impaired persons can obtain tkelley on DSKBCP9HB2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:46 Feb 15, 2019 Jkt 247001 information on this matter by contacting the Commission’s TDD terminal on 202– 205–1810. Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at 202–205–2000. General information concerning the Commission may also be obtained by accessing its internet server (https:// www.usitc.gov). The public record for these investigations may be viewed on the Commission’s electronic docket (EDIS) at https://edis.usitc.gov. SUPPLEMENTARY INFORMATION: The Commission published notice of institution of the above referenced investigations in the Federal Register on September 6, 2018 (83 FR 45281, September 6, 2018). Due to the lapse in appropriation (December 22, 2018 to January 25, 2019), the Commission has changed certain dates announced in that notice regarding these investigations: (i) It has extended the deadline for filing requests to appear at the public hearing from February 8, 2019 to March 28, 2019; (ii) it has extended the deadline for filing prehearing briefs and statements from February 13, 2019 to April 1, 2019; (iii) it has rescheduled a public hearing from February 26, 2019 to April 11 2019; (iv) it has extended the deadline for filing post-hearing briefs from March 8, 2019 to April 18, 2019; (v) it has extended the deadline for filing all other written submissions from March 15, 2019 to April 30, 2019 and (vi) it will transmit its report to the USTR by September 4, 2019 instead of by July 31, 2019. By order of the Commission. Issued: February 12, 2019. Lisa Barton, Secretary to the Commission. [FR Doc. 2019–02601 Filed 2–15–19; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Investigative No. 337–TA–1063] Certain X-Ray Breast Imaging Devices and Components Thereof; Notice of Commission Decision To Terminate the Investigation Based on Settlement; Termination of the Investigation U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that the U.S. International Trade Commission has determined to grant the private parties’ joint motion to terminate SUMMARY: PO 00000 Frm 00092 Fmt 4703 Sfmt 4703 the investigation based on settlement. The investigation is terminated. FOR FURTHER INFORMATION CONTACT: Amanda Pitcher Fisherow, Esq., Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205–2737. Copies of non-confidential documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205–2000. General information concerning the Commission may also be obtained by accessing its internet server at https://www.usitc.gov. The public record for this investigation may be viewed on the Commission’s electronic docket (EDIS) at https:// edis.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. SUPPLEMENTARY INFORMATION: The Commission instituted this investigation on August 1, 2017, based on a complaint and supplement, filed on behalf of Hologic, Inc. of Marlborough, Massachusetts. 82 FR 35823–24 (Aug. 1, 2017). The complaint, as supplemented, alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain x-ray breast imaging devices and components thereof by reason of infringement of certain claims of U.S. Patent No. 7,831,296; U.S. Patent No. 8,452,379 (‘‘the ’379 patent’’); U.S. Patent No. 7,688,940; U.S. Patent No. 7,986,765 (‘‘the ’765 patent’’); and U.S. Patent No. 7,123,684. The complaint further alleges that an industry in the United States exists as required by section 337. The notice of investigation named FUJIFILM Corporation of Tokyo, Japan; FUJIFILM Medical Systems USA, Inc. of Stamford, Connecticut; and FUJIFILM Techno Products Co., Ltd. of Hanamaki-Shi Iwate, Japan (collectively ‘‘Fujifilm’’) as respondents. The Office of Unfair Import Investigations (‘‘OUII’’) was named as a party. On January 18, 2018, the ’765 patent was terminated in its entirety from the investigation. See Order No. 18 (Jan. 18, 2018) (unreviewed). On February 27, 2018, claims 6–10 of the ’379 patent were terminated from the investigation. See Order No. 21 (Feb. 27, 2018) (unreviewed). On July 26, 2018, the administrative law judge (‘‘ALJ’’) issued the final initial E:\FR\FM\19FEN1.SGM 19FEN1 Federal Register / Vol. 84, No. 33 / Tuesday, February 19, 2019 / Notices determination (‘‘ID’’) in this investigation. The ALJ found that a violation of section 337 has occurred. On October 24, 2018, the Commission determined to review the ID in part. 83 FR 54608–10 (October 30, 3018). On February 4, 2019, Hologic and Fujifilm filed a joint motion to terminate the investigation based on a settlement. The motion includes both confidential and public versions of the settlement agreement, and the parties represent that there are no other agreements, written or oral, express or implied between them concerning the subject matter of the proceeding. The parties also contend that the termination of the investigation would not adversely affect the public interest. On February 8, 2019, OUII filed a response in support of the motion. The Commission has determined to grant the joint motion. The Commission finds that the private parties have complied with the Commission’s Rules, and that termination of the investigation would not adversely affect the public interest. The investigation is terminated. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in part 210 of the Commission’s Rules of Practice and Procedure (19 CFR part 210). By order of the Commission. Issued: February 13, 2019. Lisa Barton, Secretary to the Commission. [FR Doc. 2019–02671 Filed 2–15–19; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION comments, and the record 1 developed in the subject investigations, the Commission determines, pursuant to the Tariff Act of 1930, that an industry in the United States is materially injured by reason of subject imports of truck and bus tires from China, provided for in subheadings 4011.20.1015 and 4011.20.5020 of the Harmonized Tariff Schedule of the United States, that have been found by the Department of Commerce to be sold in the United States at less than fair value and to be subsidized by the Government of China.2 In February 2017, the Commission issued negative determinations in the antidumping and countervailing duty determinations of truck and bus tires from China. Truck and Bus Tires from China, 701–TA–556 and 731–TA–1311 (Final), USITC Pub. 4673 (March 2017). Petitioner, the United Steel, Paper and Forestry, Rubber, Manufacturing, Energy, Allied Industrial and Service Workers International Union, AFL–CIO, CLC, appealed the Commission’s negative determinations to the U.S. Court of International Trade. Following briefing and oral argument, the Court, on November 1, 2018, remanded the Commission’s determinations for reconsideration by the Commission. United Steel, Paper and Forestry, Rubber, Mfg., Energy, Allied Indus. and Serv. Workers Int’l Union v. United States, Slip Op. 18–151 (Ct. Int’l Trade Nov. 1, 2018). On January 30, 2019, the Commission on remand issued these affirmative determinations. By order of the Commission. Issued: February 12, 2019. Lisa Barton, Secretary to the Commission. [Investigation Nos. 701–TA–556 and 731– TA–1311 (Final) (Remand)] [FR Doc. 2019–02602 Filed 2–15–19; 8:45 am] Truck and Bus Tires From China BILLING CODE 7020–02–P tkelley on DSKBCP9HB2PROD with NOTICES Determinations The United States International Trade Commission (Commission) hereby publishes notice of its final determinations pursuant to the remand ordered by the U.S. Court of International Trade in the antidumping and countervailing duty investigations of truck and bus tires from China. See Diamond Sawblades Manufacturers Coalition v. United States, 626 F.3d 1374 (Fed. Cir. 2010); 19 U.S.C. 1673d(d). On the basis of the Court’s remand instructions and the parties’ VerDate Sep<11>2014 17:46 Feb 15, 2019 Jkt 247001 1 The record is defined in sec. 207.2(f) of the Commission’s Rules of Practice and Procedure (19 CFR 207.2(f)). 2 Chairman Johanson and Commissioner Broadbent dissented, finding that an industry in the United States is neither materially injured nor threatened with material injury by reason of the subject imports. PO 00000 Frm 00093 INTERNATIONAL TRADE COMMISSION [Investigation Nos. TA–131–043 and TPA– 105–004] U.S.-Japan Trade Agreement: Advice on the Probable Economic Effect of Providing Duty-Free Treatment for Currently Dutiable Imports United States International Trade Commission. ACTION: Change in date for transmittal of Commission report to the United States Trade Representative (USTR). AGENCY: The Commission has changed the date for transmittal of its report to the USTR in these investigations from January 24, 2018 to February 28, 2019 due to the lapse of appropriation between December 22, 2018 and January 25, 2019. DATES: February 11, 2019. FOR FURTHER INFORMATION CONTACT: Project Leader Justino De La Cruz (202– 205–3252 or Justino.delacruz@ustic.gov) or Deputy Project Leader Saad Ahmad (202–205–3331 or saad.ahmad@ usitc.gov) for information specific to these investigations. For information on the legal aspects of these investigations, contact William Gearhart of the Commission’s Office of the General Counsel (202–205–3091 or william.gearhart@usitc.gov). The media should contact Margaret O’Laughlin, Office of External Relations (202–205– 1819 or margaret.olaughlin@usitc.gov). Hearing-impaired persons can obtain information on this matter by contacting the Commission’s TDD terminal on 202– 205–1810. Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at 202–205–2000. General information concerning the Commission may also be obtained by accessing its internet server (https:// www.usitc.gov). The public record for these investigations may be viewed on the Commission’s electronic docket (EDIS) at https://edis.usitc.gov. SUPPLEMENTARY INFORMATION: The Commission published notice of institution of the above referenced investigations in the Federal Register on November 9, 2018 (83 FR 56100, November 9, 2018). In that notice the Commission stated that it would transmit its report to the USTR by January 24, 2019. However, due to the lapse in appropriation (December 22, 2018 to January 25, 2019), the Commission will transmit its report to the USTR by February 28, 2019. All other dates pertaining to these SUMMARY: Background Fmt 4703 Sfmt 4703 4855 E:\FR\FM\19FEN1.SGM 19FEN1

Agencies

[Federal Register Volume 84, Number 33 (Tuesday, February 19, 2019)]
[Notices]
[Pages 4854-4855]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02671]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigative No. 337-TA-1063]


Certain X-Ray Breast Imaging Devices and Components Thereof; 
Notice of Commission Decision To Terminate the Investigation Based on 
Settlement; Termination of the Investigation

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission has determined to grant the private parties' joint motion to 
terminate the investigation based on settlement. The investigation is 
terminated.

FOR FURTHER INFORMATION CONTACT: Amanda Pitcher Fisherow, Esq., Office 
of the General Counsel, U.S. International Trade Commission, 500 E 
Street SW, Washington, DC 20436, telephone (202) 205-2737. Copies of 
non-confidential documents filed in connection with this investigation 
are or will be available for inspection during official business hours 
(8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. 
International Trade Commission, 500 E Street SW, Washington, DC 20436, 
telephone (202) 205-2000. General information concerning the Commission 
may also be obtained by accessing its internet server at https://www.usitc.gov. The public record for this investigation may be viewed 
on the Commission's electronic docket (EDIS) at https://edis.usitc.gov. 
Hearing-impaired persons are advised that information on this matter 
can be obtained by contacting the Commission's TDD terminal on (202) 
205-1810.

SUPPLEMENTARY INFORMATION: The Commission instituted this investigation 
on August 1, 2017, based on a complaint and supplement, filed on behalf 
of Hologic, Inc. of Marlborough, Massachusetts. 82 FR 35823-24 (Aug. 1, 
2017). The complaint, as supplemented, alleges violations of section 
337 based upon the importation into the United States, the sale for 
importation, and the sale within the United States after importation of 
certain x-ray breast imaging devices and components thereof by reason 
of infringement of certain claims of U.S. Patent No. 7,831,296; U.S. 
Patent No. 8,452,379 (``the '379 patent''); U.S. Patent No. 7,688,940; 
U.S. Patent No. 7,986,765 (``the '765 patent''); and U.S. Patent No. 
7,123,684. The complaint further alleges that an industry in the United 
States exists as required by section 337. The notice of investigation 
named FUJIFILM Corporation of Tokyo, Japan; FUJIFILM Medical Systems 
USA, Inc. of Stamford, Connecticut; and FUJIFILM Techno Products Co., 
Ltd. of Hanamaki-Shi Iwate, Japan (collectively ``Fujifilm'') as 
respondents. The Office of Unfair Import Investigations (``OUII'') was 
named as a party. On January 18, 2018, the '765 patent was terminated 
in its entirety from the investigation. See Order No. 18 (Jan. 18, 
2018) (unreviewed). On February 27, 2018, claims 6-10 of the '379 
patent were terminated from the investigation. See Order No. 21 (Feb. 
27, 2018) (unreviewed).
    On July 26, 2018, the administrative law judge (``ALJ'') issued the 
final initial

[[Page 4855]]

determination (``ID'') in this investigation. The ALJ found that a 
violation of section 337 has occurred. On October 24, 2018, the 
Commission determined to review the ID in part. 83 FR 54608-10 (October 
30, 3018).
    On February 4, 2019, Hologic and Fujifilm filed a joint motion to 
terminate the investigation based on a settlement. The motion includes 
both confidential and public versions of the settlement agreement, and 
the parties represent that there are no other agreements, written or 
oral, express or implied between them concerning the subject matter of 
the proceeding. The parties also contend that the termination of the 
investigation would not adversely affect the public interest. On 
February 8, 2019, OUII filed a response in support of the motion.
    The Commission has determined to grant the joint motion. The 
Commission finds that the private parties have complied with the 
Commission's Rules, and that termination of the investigation would not 
adversely affect the public interest. The investigation is terminated.
    The authority for the Commission's determination is contained in 
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and 
in part 210 of the Commission's Rules of Practice and Procedure (19 CFR 
part 210).

    By order of the Commission.

    Issued: February 13, 2019.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2019-02671 Filed 2-15-19; 8:45 am]
 BILLING CODE 7020-02-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.